{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T23:11:49Z","timestamp":1791587509793,"version":"4.3.4"},"reference-count":26,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2011,6,1]],"date-time":"2011-06-01T00:00:00Z","timestamp":1306886400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2011,6,1]],"date-time":"2011-06-01T00:00:00Z","timestamp":1306886400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","pathologyjournal.rcpa.edu.au","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pathology"],"published-print":{"date-parts":[[2011,6]]},"DOI":"10.1097\/pat.0b013e3283464ca3","type":"journal-article","created":{"date-parts":[[2011,4,29]],"date-time":"2011-04-29T04:48:13Z","timestamp":1304052493000},"page":"357-361","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"title":["Challenges in the microbiological diagnosis and management of hVISA infections"],"prefix":"10.1016","volume":"43","author":[{"given":"Jenny Wan Sai","family":"Cheong","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrick","family":"Harris","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kimberly","family":"Oman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"Norton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1097\/PAT.0b013e3283464ca3_bib0005","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1007\/PL00011284","article-title":"Antibiotic susceptibility and phage typing of methicillin-resistant and -sensitive Staphylococcus aureus clinical isolates at three periods during 1991\u20131997","volume":"20","author":"Samra","year":"2001","journal-title":"EurJ Clin Microbiol Infect Dis"},{"key":"10.1097\/PAT.0b013e3283464ca3_bib0010","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1086\/596629","article-title":"Clinical features of heteroresistant vancomycin-intermediate Staphylococcus aur-eus bacteremia versus those of methicillin-resistant S. aureus bacteremia","volume":"199","author":"Maor","year":"2009","journal-title":"J Infect Dis"},{"key":"10.1097\/PAT.0b013e3283464ca3_bib0015","doi-asserted-by":"crossref","first-page":"3447","DOI":"10.1128\/AAC.01365-08","article-title":"Prospective comparison of the clinical impacts of heterogeneous vancomycin-intermediate methicillinresistant Staphylococcus aureus (MRSA) and vancomycin-susceptible MRSA","volume":"53","author":"Horne","year":"2009","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1097\/PAT.0b013e3283464ca3_bib0020","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1086\/524667","article-title":"Influence of vancomycin minimum inhibitory concentration on the treatment of methicillin-resistant Staphy-lococcus aureus bacteremia","volume":"46","author":"Soriano","year":"2008","journal-title":"Clin Infect Dis"},{"key":"10.1097\/PAT.0b013e3283464ca3_bib0025","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1128\/CMR.00042-09","article-title":"Reduced vancomycin susceptibility in staphylococcus aureus, including vancomy-cin-intermediate and heterogeneous vancomycin-intermediate strains: Re-sistance mechanisms, laboratory detection, and clinical implications","volume":"23","author":"Howden","year":"2010","journal-title":"Clin Microbiol Rev"},{"key":"10.1097\/PAT.0b013e3283464ca3_bib0030","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1086\/527392","article-title":"Vancomycin-resistant Staphylococcus aureus in the United States, 2002-2006","volume":"46","author":"Sievert","year":"2008","journal-title":"Clin Infect Dis"},{"key":"10.1097\/PAT.0b013e3283464ca3_bib0035","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1093\/jac\/40.1.135","article-title":"Methicillinresistant Staphylococcus aureus clinical strain with reduced vancomycin susceptibility","volume":"40","author":"Hiramatsu","year":"1997","journal-title":"J Antimicrob Chemother"},{"key":"10.1097\/PAT.0b013e3283464ca3_bib0040","doi-asserted-by":"crossref","first-page":"2950","DOI":"10.1128\/JCM.00582-08","article-title":"Characterization of vancomycin-heteroresistant Staphylococcus aureus from the metropolitan area of Detroit, Michigan, over a 22-year period (1986 to 2007)","volume":"46","author":"Rybak","year":"2008","journal-title":"J Clin Microbiol"},{"key":"10.1097\/PAT.0b013e3283464ca3_bib0045","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/S1473-3099(01)00091-3","article-title":"Vancomycin-resistant Staphylococcus aureus: a new model of antibiotic resistance","volume":"1","author":"Hiramatsu","year":"2001","journal-title":"Lancet Infect Dis"},{"issue":"Suppl 1","key":"10.1097\/PAT.0b013e3283464ca3_bib0050","doi-asserted-by":"crossref","first-page":"S25","DOI":"10.1086\/491711","article-title":"Vancomycin resistance in gram-positive cocci","volume":"42","author":"Courvalin","year":"2006","journal-title":"Clin Infect Dis"},{"key":"10.1097\/PAT.0b013e3283464ca3_bib0055","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1128\/JCM.41.1.5-14.2003","article-title":"Cell wall thickening is a common feature of vancomycin resistance in Staphylococcus aureus","volume":"41","author":"Cui","year":"2003","journal-title":"J Clin Microbiol"},{"key":"10.1097\/PAT.0b013e3283464ca3_bib0060","doi-asserted-by":"crossref","first-page":"1511","DOI":"10.1128\/JCM.01262-06","article-title":"Prevalence and characteristics of heteroresistant vancomycin-intermediate Staphylococcus aureus bacteremia in a tertiary care center","volume":"45","author":"Maor","year":"2007","journal-title":"J Clin Microbiol"},{"key":"10.1097\/PAT.0b013e3283464ca3_bib0065","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1093\/jac\/dkq050","article-title":"Predictors of persistent methicillin-resistant Staphylococcus aureus bacteraemia in patients treated with vancomycin","volume":"65","author":"Yoon","year":"2010","journal-title":"J Antimicrob Chemother"},{"key":"10.1097\/PAT.0b013e3283464ca3_bib0070","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1007\/s10096-009-0741-5","article-title":"Clinical features and treatment outcomes of vancomycin-intermediate Staphylococcus aureus (VISA) and heteroresistant vancomycin-intermediate Staphylococcus aureus (hVISA) in a tertiary care institution in Singapore","volume":"28","author":"Fong","year":"2009","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"10.1097\/PAT.0b013e3283464ca3_bib0075","series-title":"Methods for Dilution Antimicrobial Susceptibility Tests for Bacteria That Grow Aerobically.","year":"2009"},{"key":"10.1097\/PAT.0b013e3283464ca3_bib0080","doi-asserted-by":"crossref","first-page":"2439","DOI":"10.1128\/JCM.39.7.2439-2444.2001","article-title":"Evaluation of current methods for detection of staphylococci with reduced susceptibility to glycopeptides","volume":"39","author":"Walsh","year":"2001","journal-title":"J Clin Microbiol"},{"key":"10.1097\/PAT.0b013e3283464ca3_bib0085","doi-asserted-by":"crossref","first-page":"2637","DOI":"10.1128\/JCM.39.7.2637-2639.2001","article-title":"Practical strategies for detecting and confirming vancomycin-intermediate Staphy-lococcus aureus: a tertiary-care hospital laboratory\u2019s experience","volume":"39","author":"Marlowe","year":"2001","journal-title":"J Clin Microbiol"},{"key":"10.1097\/PAT.0b013e3283464ca3_bib0090","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1093\/jac\/47.4.399","article-title":"A modified population analysis profile (PAP) method to detect hetero-resistance to vancomycin in Staphylococcus aureus in a UK hospital","volume":"47","author":"Wootton","year":"2001","journal-title":"J Antimicrob Chemother"},{"key":"10.1097\/PAT.0b013e3283464ca3_bib0095","first-page":"2126","article-title":"Assessment of two commercial susceptibility test methods for determination of daptomycin MICs","volume":"44","author":"Jorgensen","year":"2006","journal-title":"J ClinMicrobiol"},{"key":"10.1097\/PAT.0b013e3283464ca3_bib0100","series-title":"Performance Standards for Antimicrobial Susceptibility Testing; Twentieth Informational Supple-ment.","year":"2010"},{"key":"10.1097\/PAT.0b013e3283464ca3_bib0105","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1128\/JCM.01508-06","article-title":"A multicenter study evaluating the current strategies for isolating Staphylococcus aureus strains with reduced susceptibility to glycopeptides","volume":"45","author":"Wootton","year":"2007","journal-title":"J Clin Microbiol"},{"key":"10.1097\/PAT.0b013e3283464ca3_bib0110","doi-asserted-by":"crossref","first-page":"1936","DOI":"10.1016\/j.clinthera.2009.09.012","article-title":"Clinical outcomes of patients receiving daptomycin for the treatment of Staphylo-coccus aureus infections and assessment of clinical factors for daptomycin failure: a retrospective cohort study utilizing the Cubicin Outcomes Reg-istry and Experience","volume":"31","author":"Sakoulas","year":"2009","journal-title":"Clin Ther"},{"key":"10.1097\/PAT.0b013e3283464ca3_bib0115","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1016\/S1473-3099(09)70200-2","article-title":"Susceptibility relation-ship between vancomycin and daptomycin in Staphylococcus aureus: facts and assumptions","volume":"9","author":"Moise","year":"2009","journal-title":"Lancet Infect Dis"},{"key":"10.1097\/PAT.0b013e3283464ca3_bib0120","doi-asserted-by":"crossref","first-page":"1132","DOI":"10.1128\/JCM.01844-07","article-title":"Bacteremia and infective endocarditis caused by a non-daptomycin-susceptible, vancomy-cin-intermediate, and methicillin-resistant Staphylococcus aureus strain in Taiwan","volume":"46","author":"Huang","year":"2008","journal-title":"J Clin Microbiol"},{"key":"10.1097\/PAT.0b013e3283464ca3_bib0125","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1093\/jac\/dkn520","article-title":"Evaluation of the Etest GRD for the detection of Staphylococcus aureus with reduced susceptibility to glycopeptides","volume":"63","author":"Leonard","year":"2009","journal-title":"J Antimicrob Chemother"},{"key":"10.1097\/PAT.0b013e3283464ca3_bib0130","doi-asserted-by":"crossref","first-page":"3042","DOI":"10.1128\/JCM.00265-08","article-title":"Evaluation of a new Etest vancomycin-teicoplanin strip for detection of glycopeptide-intermediate Staphylococcus aureus (GISA), in particular, heterogeneous GISA","volume":"46","author":"Yusof","year":"2008","journal-title":"J Clin Microbiol"}],"container-title":["Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0031302516330045?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0031302516330045?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,21]],"date-time":"2025-09-21T16:15:14Z","timestamp":1758471314000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0031302516330045"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,6]]},"references-count":26,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2011,6]]}},"alternative-id":["S0031302516330045"],"URL":"https:\/\/doi.org\/10.1097\/pat.0b013e3283464ca3","relation":{},"ISSN":["0031-3025"],"issn-type":[{"value":"0031-3025","type":"print"}],"subject":[],"published":{"date-parts":[[2011,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Challenges in the microbiological diagnosis and management of hVISA infections","name":"articletitle","label":"Article Title"},{"value":"Pathology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1097\/PAT.0b013e3283464ca3","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2011 Royal College of Pathologists of Australasia. Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}